P2.09. Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Wei Wang
Meta Tag
Speaker Wei Wang
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
Leptomeningeal metastasis
EGFR mutations
intrathecal chemotherapy
Ommaya reservoir
progression-free survival
cerebrospinal fluid
cfDNA profiles
clinical trial
Powered By